About Diabetes Meet 2020 Conference Series takes the immense Pleasure to invite participants from all over the world to attend the 3rdInternational conference on Diabetes, Hypertension and [...]
ABOUT 3RD INTERNATIONAL CONFERENCE ON CARDIOLOGY AND HEART DISEASES The standard goal of Cardiology 2020 is to move the cardiology results and improvements and to [...]
ABOUT MEDICAL DEVICE DEVELOPMENT EXPO OSAKA What is Medical Device Development Expo OSAKA (MEDIX OSAKA)? Gathers All Kinds of Technologies for Medical Device Development! This [...]
Groundbreaking Event to Address Asia-Pacific’s Growing Beauty Sector—Your Window to the World’s Fastest Growing Beauty Market The international cosmetics industry has experienced a rapid rise [...]
IASTEM - 789th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 4th - 5th March, 2020 at Hamburg, Germany . [...]
Innovative solutions to the greatest challenges in pharmaceutical development. Price: Full price delegate ticket: GBP 1495.0. Time: 9:00 am to 6:00 pm About Conference KC [...]
Confidently Translate, Develop and Commercialize Gene, mRNA, Replacement Therapies, Small Molecule and Substrate Reduction Therapies to More Efficaciously Treat Inherited Metabolic Diseases. Time: 8:00 am [...]
Overview: This session will focus on the rights of individuals to communicate in the manner they desire, and how a medical office can decide what [...]
Topics in Family Medicine, Hematology, and Oncology CME Cruise. Prices: USD 495.0 to USD 895.0. Speakers: David Parrish, MS, MD, FAAFP, Alexander E. Denes, MD, [...]
An elegant and rich premier global platform for the International Conference on Healthcare and Clinical Gerontology ICHCG that uniquely describes the Academic research and development [...]
"The world best platform for all the researchers to showcase their research work through OralPoster presentations in front of the international audience, provided with additional [...]
About Conference: Conference Series LLC Ltd is overwhelmed to announce the commencement of “25th International Conference on Diabetes, Endocrinology and Healthcare” to be held during [...]
ABOUT ISN WORLD CONGRESS OF NEPHROLOGY 2020 ISN World Congress of Nephrology (WCN) takes place annually to enable this premier educational event more available to [...]
This Cardio Diabetes 2020 includes Speaker talks, Keynote & Poster presentations, Exhibition, Symposia, and Workshops. This International Conference will help in interacting and meeting with diabetes and [...]
Trending Topics in Internal Medicine is a CME course that will tackle the latest information trending in healthcare today. This course will help you discuss options [...]
The 2020 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer [...]
Austin, TX – May 03, 2024 – WSO2, the leader in digital transformation technology, announced today that it has signed a definitive agreement to be acquired by EQT.
“We are thrilled to partner with EQT as we embark on the next phase of WSO2’s journey,” said Dr. Sanjiva Weerawarana, CEO and Founder of WSO2. “With EQT’s support and expertise, we are well-positioned to accelerate our innovation agenda, expand our global footprint, and continue empowering enterprises to thrive in the digital economy.”
Since its inception in 2005, WSO2 has been at the forefront of building innovative software that allows organizations to seamlessly deliver digital experiences. Today, WSO2’s platform offers a complete set of market leading solutions across integration, API management, identity & access management (IAM) and application development. Thousands of organizations, including hundreds of the world’s largest corporations, top universities, and governments, rely on WSO2’s cloud native software as a service (SaaS) and open-source offerings to drive their digital initiatives — executing 60 trillion transactions and managing over 1 billion identities each year.
With EQT as its new partner, WSO2 reaffirms its commitment to delivering innovative solutions that address the evolving needs of modern businesses.
Looking ahead, “WSO2 remains focused on driving customer success, fostering community collaboration, and delivering innovative software that unlocks new value creation opportunities for organizations worldwide,” added Weerawarana.
Hari Gopalakrishnan, Partner in the EQT Private Capital Asia advisory team, said: “We’re excited to partner with WSO2 as it helps customers across industries drive their digital transformation and enhance operational resilience. We believe that WSO2 is well-positioned to capitalize on long-term trends such as digital transformation and rising generative AI adoption and are confident of drawing on EQT’s proven software value creation playbook to further accelerate WSO2’s strong growth.”
EQT is a purpose-driven global investment organization with EUR 242 billion in total assets under management and the third largest private equity firm globally*. Founded three decades ago by the Swedish Wallenberg family, today EQT owns portfolio companies and assets in Europe, Asia-Pacific and the Americas and supports them in achieving sustainable growth, operational excellence and market leadership. EQT’s extensive global portfolio of enterprise software companies includes firms such as IFS, SUSE, thinkproject, and more.
The transaction is subject to customary conditions and approvals. J.P. Morgan served as exclusive financial advisor to WSO2.
About WSO2
Founded in 2005, WSO2 is the largest independent software vendor providing open-source API management, integration, and identity and access management (IAM) products. WSO2’s products and platforms—including our next-gen internal developer platform, Choreo—empower organizations to leverage the full potential of APIs for secure delivery of digital services and applications, enabling thousands of enterprises in over 90 countries globally to drive their digital transformation journeys. Our open-source, API-first approach frees developers and architects from vendor lock-in, enabling rapid digital product creation. Recognized as leaders by industry analysts, WSO2 has over 800 employees worldwide with offices in Australia, Brazil, Germany, India, Sri Lanka, the UAE, the UK, and the US, with nearly USD100M in annual recurring revenue. Visithttps://wso2.com to learn more. Follow WSO2 onLinkedIn andX (formerly Twitter).
Trademarks and registered trademarks are the properties of their respective owners.
